{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:48:19Z","timestamp":1780400899117,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12020-016-1167-3","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T13:24:58Z","timestamp":1479216298000},"page":"394-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Tablet and oral liquid L-thyroxine formulation in the treatment of na\u00efve hypothyroid patients with Helicobacter pylori infection"],"prefix":"10.1007","volume":"57","author":[{"given":"Danilo","family":"Ribichini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Repaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"1167_CR1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka; American Thyroid Association Task Force on Thyroid Hormone Replacement, Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24, 1670\u20131751 (2014)","journal-title":"Thyroid."},{"key":"1167_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.1995.5.249","volume":"5","author":"S Benvenga","year":"1995","unstructured":"S. Benvenga, L. Bartolone, S. Squadrito, F. Lo Giudice, F. Trimarchi, Delayed intestinal absorption of levothyroxine. Thyroid. 5, 249\u2013253 (1995)","journal-title":"Thyroid."},{"key":"1167_CR3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1089\/thy.2012.0435","volume":"23","author":"CL Perez","year":"2013","unstructured":"C.L. Perez, F.S. Araki, H. Graf, G.A. de Carvalho, Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 23, 779\u2013784 (2013)","journal-title":"Thyroid."},{"key":"1167_CR4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/17425247.2014.918101","volume":"11","author":"R Vita","year":"2014","unstructured":"R. Vita, P. Fallahi, A. Antonelli, S. Benvenga, The administration of L-thyroxine as soft gel capsule or liquid solution. Expert. Opin. Drug. Deliv. 11, 1103\u20131111 (2014)","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"1167_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0026-0495(77)90121-4","volume":"26","author":"KW Wenzel","year":"1977","unstructured":"K.W. Wenzel, H.E. Kirschsieper, Aspects of the absorption of oral L-thyroxine in normal man. Metabolism. 26, 1\u20138 (1977)","journal-title":"Metabolism."},{"key":"1167_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12020-012-9814-9","volume":"43","author":"M Centanni","year":"2013","unstructured":"M. Centanni, Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine. 43, 8\u20139 (2013)","journal-title":"Endocrine."},{"key":"1167_CR7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"L. Liwanpo, J.M. Hershman, Conditions and drugs interfering with thyroxine absorption. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 781\u2013792 (2009)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1167_CR8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1046\/j.1365-2036.2000.00837.x","volume":"14","author":"G Sachs","year":"2000","unstructured":"G. Sachs, J.M. Shin, K. Munson, O. Vagin, N. Lambrecht, D.R. Scott, D.L. Weeks, K. Melchers, Review article: the control of gastric acid and Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 14, 1383\u20131401 (2000)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1167_CR9","unstructured":"Rome III Diagnostic Criteria for FGIDs (2016), http:\/\/www.romecriteria.org\/assets\/pdf\/19_RomeIII_apA_885-898.pdf Accessed 18 Jul 2016."},{"key":"1167_CR10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2036.2009.03993.x","volume":"29","author":"E Lahner","year":"2009","unstructured":"E. Lahner, B. Annibale, G. Delle Fave, Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy. Aliment. Pharmacol. Ther. 29, 1219\u20131229 (2009a)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1167_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2008.03906.x","volume":"29","author":"E Lahner","year":"2009","unstructured":"E. Lahner, B. Annibale, G. Delle Fave, Systematic review: helicobacter pylori infection and impaired drug absorption. Aliment. Pharmacol. Ther. 29, 379\u2013386 (2009b)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1167_CR12","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","volume":"354","author":"M Centanni","year":"2006","unstructured":"M. Centanni, L. Gargano, G. Canettieri, N. Viceconti, A. Franchi, G. Delle Fave, B. Annibale, Thyroxine in goiter, helicobacter pylori infection, and chronic gastritis. N. Engl. J. Med. 354, 1787\u20131795 (2006)","journal-title":"N. Engl. J. Med."},{"key":"1167_CR13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199512213332507","volume":"333","author":"MI Surks","year":"1995","unstructured":"M.I. Surks, R. Sievert, Drugs and thyroid function. N. Engl. J. Med. 333, 1688\u20131694 (1995)","journal-title":"N. Engl. J. Med."},{"key":"1167_CR14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1365-2036.2008.03846.x","volume":"28","author":"N Vakil","year":"2008","unstructured":"N. Vakil, A. Zullo, C. Ricci, C. Hassan, D. Vaira, Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients. Aliment. Pharmacol. Ther. 28, 1304\u20131308 (2008)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1167_CR15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12020-016-0882-0","volume":"52","author":"AM Formenti","year":"2016","unstructured":"A.M. Formenti, G. Mazziotti, R. Giubbini, A. Giustina, Treatment of hypothyroidism: all that glitters is gold? Endocrine. 52, 411\u2013413 (2016)","journal-title":"Endocrine."},{"key":"1167_CR16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11695-013-1015-y","volume":"23","author":"I Pirola","year":"2013","unstructured":"I. Pirola, A.M. Formenti, E. Gandossi, F. Mittempergher, C. Casella, B. Agosti, C. Cappelli, Oral liquid L-thyroxine (l-T4) may be better absorded compared to l-T4 tablets following bariatric surgery. Obes. Surg. 23, 1493\u20131496 (2013)","journal-title":"Obes. Surg."},{"key":"1167_CR17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jpeds.2012.11.070","volume":"162","author":"A Cassio","year":"2013","unstructured":"A. Cassio, S. Monti, A. Rizzello, I. Bettocchi, F. Baronio, G. D\u2019Addabbo, M.O. Bal, A. Balsamo, Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J. Pediatr. 162, 1264\u20131269 (2013)","journal-title":"J. Pediatr."},{"key":"1167_CR18","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1210\/jc.2014-2684","volume":"12","author":"R Vita","year":"2014","unstructured":"R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J. Clin. Endocrinol. Metab. 12, 4481\u20134486 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1167_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.2015.0422","volume":"26","author":"C Cappelli","year":"2016","unstructured":"C. Cappelli, I. Pirola, L. Daffini, A. Formenti, C. Iacobello, A. Cristiano, E. Gandossi, E. Agabiti Rosei, M. Castellano, A double-blind placebo-controlled trial of liquid thyroxine Ingested at breakfast: results of the TICO study. Thyroid. 26, 197\u2013202 (2016)","journal-title":"Thyroid."},{"key":"1167_CR20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12020-015-0788-2","volume":"52","author":"S Morelli","year":"2016","unstructured":"S. Morelli, G. Reboldi, S. Moretti, E. Menicali, N. Avenia, E. Puxeddu, Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation. Endocrine. 52, 571\u2013578 (2016)","journal-title":"Endocrine."},{"key":"1167_CR21","doi-asserted-by":"publisher","unstructured":"P. Fallahi, S.M. Ferrari, I. Ruffilli, A. Antonelli: Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series. BMC Gastroenterol (2016). doi: 10.1186\/s12876-016-0439-y","DOI":"10.1186\/s12876-016-0439-y"},{"key":"1167_CR22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12020-015-0836-y","volume":"52","author":"P Fallahi","year":"2016","unstructured":"P. Fallahi, S.M. Ferrari, A. Antonelli, Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine. 52, 597\u2013601 (2016)","journal-title":"Endocrine."},{"key":"1167_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1590-8658(00)80278-9","volume":"32","author":"KE McColl","year":"2000","unstructured":"K.E. McColl, Helicobacter pylori and dyspepsia. Pro and against. Dig. Liver. Dis. 32, 199\u2013201 (2000)","journal-title":"Dig. Liver. Dis."},{"key":"1167_CR24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1152\/ajpcell.1998.274.4.C1011","volume":"274","author":"M Feldman","year":"1998","unstructured":"M. Feldman, B. Cryer, E. Lee, Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings. Am. J. Physiol. 274, 1011\u20131017 (1998)","journal-title":"Am. J. Physiol."},{"key":"1167_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12020-014-0476-7","volume":"49","author":"MG Santaguida","year":"2015","unstructured":"M.G. Santaguida, C. Virili, S.C. Del Duca, M. Cellini, I. Gatto, N. Brusca, C. De Vito, L. Gargano, M. Centanni, Thyroxine softgel capsule in patients with gastric-related T4 malabsortion. Endocrine. 49, 51\u201357 (2015)","journal-title":"Endocrine."},{"key":"1167_CR26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1523-5378.2011.00830.x","volume":"16","author":"MS Bugdaci","year":"2011","unstructured":"M.S. Bugdaci, S.S. Zuhur, M. Sokmen, B. Toksoy, B. Bayraktar, Y. Altuntas, The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine. Helicobacter. 16, 124\u2013130 (2011)","journal-title":"Helicobacter."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1167-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T16:09:56Z","timestamp":1568563796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1167-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["1167"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1167-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}